According to figures released this morning by Dow Jones VentureSource, 21 NYC-area biotech startups have been funded so far this year, down from 28 by the end of the third quarter of 2010. The dollar amounts have dropped, too: VCs have invested just $200 million in New York biotechs so far this year, compared to $294 million invested through Q3 last year.
If we’re to have any hope of matching last year’s haul—37 New York biotechs raised a total of $384.4 million in 2010—we’ll need to see some big deals, and fast.
To read the full, original article click on this link: Biotech Funding in New York: We Have Some Catching Up to Do | Xconomy
